Population
Patients with heart failure
Design
Review
Authors
Loading...
NT-proBNP preferred for HF assessment due to superior assay performance; leaves open outcome impact in diverse populations.
Clinicians must account for assay characteristics and clinical context, such as ARNI therapy, when interpreting BNP and NT-proBNP levels in heart failure.
Clerico et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: